支气管镜介入治疗联合帕博利珠单抗治疗肺大细胞神经内分泌癌 1 例报告。
Bronchoscopic Interventional Therapy Combined With Pembrolizumab in the Treatment of Pulmonary Large Cell Neuroendocrine Carcinoma: A Case Report.
机构信息
Department of Respiratory and Critical Care Medicine, Shengli Oilfield Central Hospital, Dongying, China.
Clinical Pharmacy of Pharmacy Department, Shengli Oilfield Central Hospital, Dongying, China.
出版信息
Clin Respir J. 2024 Sep;18(9):e70009. doi: 10.1111/crj.70009.
Abstract
This study reports a significant clinical outcome following the use of bronchoscopic interventional therapy combined with pembrolizumab for treating pulmonary large cell neuroendocrine carcinoma (LCNEC), showcasing a novel approach in managing this aggressive cancer.
摘要
本研究报告了经支气管镜介入治疗联合 pembrolizumab 治疗肺大细胞神经内分泌癌（LCNEC）的显著临床疗效，为治疗这种侵袭性癌症提供了一种新的方法。
Zotero 插件